RAC 0.00% $1.69 race oncology ltd

Partner deal will rocket stock., page-8

  1. 11,719 Posts.
    lightbulb Created with Sketch. 1694
    The thing is rac's drug has already successfully passed a number of phase 2 trials, and shown to have a great safety profile - so it's practically risk free for a suitor. Then a big market awaits.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.